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We have demonstrated previously that IFN- plays a protec-
tive role in the initiation of chronic intestinal inflammation
through attenuation of Toll-like receptor-mediated IL-23 in-
duction in macrophages. Here, an interferon-stimulated re-
sponse element (ISRE) is identified in a region of conserved
nucleotide sequences in the Il23a promoter. This ISRE medi-
ated, in part, Il23a promoter induction by LPS and inhibition
of LPS-induced activity by IFN-. LPS and IFN- recruit inter-
feron regulatory factors (IRFs) to the Il23a ISRE in murine
bone marrow-derived macrophages (BMMs). Functionally,
IRF-1 is a negative regulator of Il23a in LPS-stimulated
BMMs. IRF-1/ BMMs demonstrated enhanced LPS-induced
Il23a expression compared withWT BMMs. Moreover, IRF-1
deficiency resulted in prolonged occupancy of RelA on the
Il23a promoter. Consequently, IRF-1/ mice were more sus-
ceptible to colonic injury by trinitrobenzenesulfonic acid, and
IL-10/IRF-1 double-deficient (IL-10/IRF-1/) mice demon-
strated more severe colonic inflammation compared with IL-
10/ mice. The severity of colitis in both models correlated
with increased colonic IL-23. CD11b lamina propria mono-
nuclear cells, comprising predominantly macrophages, were
identified as the major source of IL-23 in colitis-prone mice.
Basal and heat-killed Escherichia coli-stimulated levels of
Il23a were increased in IL-10/IRF-1/ compared withWT
and IL-10/ colonic CD11b lamina propria mononuclear
cells. In conclusion, these experiments characterize IRF-ISRE
interactions on the Il23a promoter, which have in vivo rele-
vance as a homeostatic checkpoint in chronic intestinal
inflammation.
IL-23 is a heterodimeric cytokine composed of a p19 sub-
unit (Il23a) and a p40 subunit (Il12b) also shared with IL-12.
Il23a is expressed in macrophages and dendritic cells and is
induced by microbial products such as LPS (1). The impor-
tance of IL-23 in the pathogenesis of chronic inflammatory
disorders is supported by the recent identification of IL-23
receptor susceptibility alleles associated with the inflamma-
tory bowel diseases, psoriasis, and spondyloartropathies (2).
IL-23-driven inflammation has been linked to its role in the
development and persistence of a pathogenic subset of T-
helper type 17 (TH17) cells (3).
Recently, we demonstrated a protective role for IFN-, the
signature TH1 cytokine, in chronic intestinal inflammation
through attenuation of Il23a gene expression (4). IFN- re-
ceptor deficiency exacerbated IL-23-mediated colitis in IL-10-
deficient (IL-10/) mice. Although the molecular regulation
of IL-12 p35 (Il12a) and Il12b expression has been well stud-
ied, many important questions remain about Il23a regulation
in macrophages (1).
Toll-like receptors (TLRs)2 induce Il23a expression in
macrophages through recruitment of NF-B family members
to binding sites in the proximal promoter (5). We demon-
strated that IFN- inhibited LPS-induced NF-B RelA while
enhancing p50 subunit recruitment to the Il23a promoter (4).
IFN--mediated IL-23 inhibition was in striking contrast to
its augmentation of LPS-induced IL-12 p40 and IL-12 p70
expression (4). Notably, TLR and IFN- transcriptional re-
sponse in the Il12a and Il12b promoters is mediated by inter-
feron regulatory factor (IRF) family members (1). Specifically,
mice deficient in IRF-1, IRF-2, and IRF-8 demonstrate defects
in Il12a and Il12b production (6). The reciprocal regulation of
IL-12 family members by IFN- highlights its complex biolog-
ical role in the maintenance of immune homeostasis.
In these experiments, we functionally characterize an inter-
feron-stimulated response element (ISRE) in the Il23a pro-
moter. This ISRE mediated Il23a promoter induction by LPS
and inhibition of LPS-induced activity by IFN-. LPS- and
IFN--induced IRF-1 is identified as a negative regulator of
IL-23 in macrophages and experimental colitis.
EXPERIMENTAL PROCEDURES
Mice—WT, IL-10/, NF-B p50/, and IRF-1/ mice
on a C57BL/6 background were matched for age in all experi-
ments. IRF-1/IL-10/ mice were obtained by crossing IL-
10/ and IRF-1/ mice. Heterozygous offspring were then
bred to obtain homozygous IL-10/IRF-1/ mice. Age-
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matched littermates were used as controls. 8–10-week-old
WT and IRF-1/ mice were administered 2.5% (w/v) trini-
trobenzenesulfonic acid (TNBS) in 40% ethanol intrarectally,
and intestines were harvested for analyses after 5 days of
treatment. All mice were housed in accordance with guide-
lines from the American Association for Laboratory Animal
Care, and research protocols were approved by the Institu-
tional Animal Care and Use Committee of the University of
North Carolina.
Reagents and Plasmids—Highly purified LPS and IFN-
were obtained from InvivoGen (San Diego, CA). Heat-killed
E. coli K12 cells were prepared as described previously (4).
Murine IL-12 p40, IL-12 p70, and immunoassay kits (R&D
Systems, Minneapolis, MN) and IL-23 (eBioscience, San Di-
ego, CA) were used according to the manufacturers’ instruc-
tions. The 1.8-kb Il23a-luciferase construct was provided Dr.
Y. H. Chen (University of Pennsylvania School of Medicine).
The QuikChange XL system (Stratagene, Santa Clara, CA)
was used to make mutations in the ISRE in the Il23amurine
promoter. Mutations were confirmed by sequencing.
Bone Marrow-derived Macrophages—Bone marrow-derived
macrophages (BMMs) were prepared as described (7).
Western Immunoblot—Western blotting was performed on
whole cell extracts as described (7). Anti-IRF-1 antibodies
were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA),
and anti--actin antibodies were from Abcam (Cambridge,
MA).
Quantitative Real-time PCR—Real-time PCR was per-
formed as described previously (8). Primer sequences are in-
cluded in supplemental Table 1.
Transient Transfections—BMMs were transiently trans-
fected using Amaxa Nucleofector technology (4). Cells were
cotransfected with a constitutively active heat shock protein
promoter that expresses -galactosidase to monitor transfec-
tion efficiency. IRF-1 siRNA and control scrambled siRNA
were purchased from Santa Cruz Biotechnology, Inc.
Colonic Tissue Explant Cultures—Sections of the transverse
colon were processed for cytokine analysis as described previ-
ously (8).
Colonic Macrophage Isolation—Lamina propria mononu-
clear cells (LPMCs) were isolated from mouse colon by a
modified enzymatic method (9). LPMCs were separated into
CD11b cells using anti-CD11b microbeads (Miltenyi Biotec,
Auburn, CA). Purity was 90% by flow cytometric analysis
(data not shown).
Histology—Histological colitis scores were determined on
colonic tissue sections by a staff pathologist (Tara Rubinas),
who was blinded to the experimental protocols, as described
(8).
ChIP—ChIP was performed with the ChIP-IT Express kit
(Active Motif, Carlsbad, CA) as described (4). DNA-protein
complexes were immunoprecipitated with anti-IRF-1, anti-
RelA, and rabbit polyclonal IgG antibodies (Santa Cruz Bio-
technology, Inc.). Real-time PCR primers (supplemental Ta-
ble 1) amplified a 198-bp product in immunoprecipitated and
input DNA (diluted 10-fold).
EMSA—BMM nuclear extracts were prepared by the modi-
fied Dignam protocol as described previously (10). BMMs
were untreated or treated with LPS (100 ng/ml) with or with-
out IFN- (10 ng/ml). Synthetic double-stranded oligonucleo-
tides were designed to span the Il23a promoter region from
368 to 388 bp. The EMSA probe 368/388m contains a
mutated sequence from 372 to 378 bp. EMSAs were per-
formed as described previously (10). For competition experi-
ments, a 100-fold molar excess of unlabeled oligonucleotides
was added to the reaction mixture before adding labeled
probes. For supershift assays, 1.5 g of rabbit polyclonal anti-
bodies to IRF-1, -2, and -8 (Santa Cruz Biotechnology, Inc.)
was added to nuclear extracts 30 min prior to the probe.
Statistical Analyses—Statistical significance from experi-
ments in cells was determined using the Wilcoxon signed-
rank test. Statistical significance for in vivo data was assessed
by the Mann-Whitney U test (SPSS, Chicago, IL) with Bonfer-
roni correction.
RESULTS
Characterization of an ISRE in the Il23a Promoter—To lo-
calize potentially important regulatory regions, conserved
nucleotide sequences were identified in multiple species in
the Il23a gene locus (supplemental Fig. 1). Within a con-
served nucleotide sequence in the murine Il23a promoter, a
putative ISRE was identified at 378 to 384 bp with respect
to the transcription start site (Fig. 1A).
IRFs Interact with the Il23a ISRE—To determine DNA-
protein interactions at this ISRE, EMSA and ChIP experi-
ments were performed. An EMSA probe that spans Il23a pro-
moter sequence 368 to 388 (368/388) containing the ISRE
demonstrated enhanced DNA-protein interactions (Fig. 1B,
complexes I and II, lanes 3–11) when incubated with nuclear
extracts from LPS- and IFN--activated BMMs compared
with extracts from unstimulated cells (Fig. 1B, lane 2). An
EMSA probe (368/388m) with a mutated sequence from
378 to 384 bp within the ISRE demonstrated decreased
DNA binding of complexes I and II (Fig. 1B, lane 12). Like-
wise, competition experiments with unlabeled double-
stranded oligonucleotides corresponding to probe 368/388
(368/388u) (Fig. 1B, lane 6) revealed competition of complex I
and II DNA binding. When nuclear extracts from LPS- and
IFN--stimulated BMMs were preincubated with specific an-
tibodies to IRF-1 but not IRF-2, IRF-8, and c-Rel, inhibition
and supershift of complexes I and II were observed (Fig. 1B,
lanes 7–10).
Next, BMMs were cultured with LPS/IFN-, and occu-
pancy of IRF-1 on the ISRE site was analyzed by ChIP using
primers that span the Il23a promoter from 343 to 521 bp.
LPS induced IRF-1 recruitment to the ISRE on the Il23a pro-
moter. IRF-1 promoter occupancy was enhanced by the addi-
tion of IFN- (Fig. 1C).
Next, a 1.8-kb Il23a promoter-luciferase reporter plasmid
containing the ISRE was transiently transfected into BMMs.
As reported previously, LPS strongly induced Il23a promoter
activity and IFN- inhibited luciferase activity (4). BMMs
transfected with a reporter plasmid containing a site-directed
mutation within the ISRE also demonstrated LPS-induced
luciferase activity (Fig. 1D). Importantly, IFN- strongly in-
hibited the LPS-induced luciferase activity of the WT pro-
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moter (4), but when the ISRE was mutated, the inhibitory ef-
fect of IFN- was abrogated. Given that IRF-1 interacts with
the ISRE, the WT Il23a promoter-luciferase plasmid was ex-
pressed in IRF-1/ BMMs. Interestingly, significantly higher
basal and LPS-induced promoter activities were demon-
strated, and the inhibitory effect of IFN- on LPS-induced
activity was diminished (Fig. 1D). These results show that in-
teractions on or around this ISRE are important for the in-
duction and inhibition of Il23a by LPS and IFN- and suggest
a prominent role for IRF-1 in Il23a regulation.
IRF-1 Negatively Regulates Il23a Gene Expression in
BMMs—The functional role of IRF-1 in endogenous Il23a
regulation was determined next. LPS-activated IRF-1/
BMMs demonstrated increased expression of Il23a (Fig. 2A)
and IL-23 protein (Fig. 2B) compared with WT BMMs. In the
presence of IFN-, IL-23 levels were higher in IRF-1/
BMMs than in LPS-activated WT BMMs, although inhibi-
tion of LPS-induced IL-23 was still apparent (Fig. 2, A and
B). LPS- and IFN--stimulated IRF-1/ BMMs showed
reduced levels of IL-12 p70 (Fig. 2C) and minimal differ-
ences in IL-12 p40 (Fig. 2D) compared with WT BMMs, as
reported previously (11). To validate these findings, IRF-1
expression in WT BMMs was inhibited using siRNA. Irf1
siRNA effectively decreased IRF-1 expression (Fig. 2E).
LPS-induced Il23a expression was increased in WT BMMs
transfected with Irf1 siRNA compared with cells trans-
fected with scrambled siRNA (Fig. 2F). An inhibitory effect
of IFN- on LPS-induced Il23a expression was still ob-
served in Irf1 siRNA transfected BMMs. These results im-
plicate IRF-1 as a negative regulator of LPS-induced Il23a.
However, IRF-1 is not solely responsible for IFN--medi-
ated inhibition of IL-23.
IRF-1 Abrogates RelA Binding to the Il23a Promoter—Two
NF-B sites have been implicated previously in LPS-induced
FIGURE 1. Characterization of an ISRE in the Il23a promoter. A, schematic representation of the murine Il23a promoter region. The NF-B sites desig-
nated 1, 2, and 3 are 82, 618, and 960 bp, respectively, and ISRE is 378 upstream of the transcription initiation site (TIS). The luciferase reporter con-
struct (Il23a luc) contains all three putative NF-B sites and the ISRE upstream of the firefly luciferase (luc) open reading frame. B, EMSA probe 368/388 spans
Il23a promoter sequence 368 to 388. The EMSA probe 368/388m contains a mutant ISRE from 378 to 384 bp. 32P-Labeled probes 368/388 (lanes
2– 4) and 368/388m (lane 12) were incubated with nuclear extracts from untreated (lane 2), LPS-activated (lane 3), IFN--activated (lane 4), and IFN-- and
LPS-activated (lanes 5–12) BMMs. Lane 1 represents free probe (FP). Two DNA-protein complexes (I and II) were detected with probe 368/388. A 100-fold
molar excess of unlabeled probe (368/388u) (lane 6) was added to compete for binding. Probe 368/388 was incubated with nuclear extracts from IFN-/LPS-
treated BMMs cells for 30 min, and then polyclonal antibodies against IRF-1, IRF-2, and IRF-8 (lanes 7–9) and c-Rel (lane 10) were added. The figure repre-
sents similar results from one of three independently conducted experiments. C, chromatin samples from BMMs treated with LPS (100 ng/ml) and IFN- (10
ng/ml) were immunoprecipitated with anti-IRF-1 and rabbit polyclonal IgG antibodies. Quantitative real-time PCR analysis was performed on precipitated
and input DNA. Results are reported as enrichment (% input) of IRF-1 DNA binding. Data represent the mean  S.E. of three independent experiments. **,
p  0.01 versus unstimulated (Un) Il23a promoter. D, WT BMMs were transfected with an Il23a promoter-luciferase reporter plasmid (Il23a luc) or a plasmid
containing a mutant ISRE (Il23a mut luc), and IRF-1/ BMMs were transfected with the Il23a-luciferase reporter and then cultured with LPS (100 ng/ml;
black bars)  IFN- (10 ng/ml; gray bars) for 18 h. Reporter activity is presented as luciferase units normalized to heat shock protein promoter -galactosid-
ase activity. Data represent the mean  S.E. of three independent experiments. *, p  0.05 versus the LPS-stimulated Il23a promoter-luciferase reporter in
WT BMMs.
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activation of the Il23a promoter (5, 12). The ISRE is critically
positioned between two NF-B sites implicated in LPS-in-
duced activation of the Il23a promoter (5, 12). We recently
demonstrated that IFN- abrogates LPS-induced RelA occu-
pancy on the distal Il23a NF-B-binding site (4). Therefore,
the role of IRF-1 in RelA recruitment was assessed in ChIP
assays using PCR primers (from 549 to 680 bp) spanning
the distal NF-B site on the Il23a promoter. As described pre-
viously (4), in LPS-activated WT BMMs, RelA promoter oc-
cupancy was increased by 30 min but rapidly returned to near
base line by 1 h. In LPS-induced IRF-1/ BMMs, RelA occu-
pancy was prolonged through 1 h compared with WT BMMs
(Fig. 3A).
Recruitment of the NF-B p50 subunit to gene promoters
is associated with transcriptional repression (12). The role of
IRF-1 in p50 recruitment to the distal NF-B site on the Il23a
promoter was next determined in ChIP experiments. In con-
trast to RelA, in WT BMMs, no basal occupancy of NF-B
p50 on the Il23a promoter was detected, but promoter occu-
pancy was increased 60 min following LPS stimulation (Fig.
3B), correlating with attenuation of Il23amRNA expression
(4). Unlike WT BMMs, IRF-1/ BMMs demonstrated ele-
vated base-line association of NF-B p50 with the Il23a pro-
moter that was markedly abrogated 60 min following LPS ac-
tivation (Fig. 3B). Validating the functional significance of
IRF-1-mediated differential recruitment of NF-B subunits to
the Il23a promoter, Il23amRNA (Fig. 3C) and IL-23 protein
(Fig. 3D) induction was significantly greater in LPS-activated
NF-B p50/ BMMs compared with WT BMMs (Fig. 3).
Increased Mucosal Expression of IL-23 Correlates with Se-
vere Colonic Inflammation in TNBS-treated IRF-1/ Mice
and IRF-1/IL-10/ Mice—To discern the biological effects
of IRF-1 deficiency on the initiation of colonic inflammation,
colitis was induced in WT and IRF-1/ mice by rectal ad-
ministration of the hapten TNBS. Compared with WT mice
on the C57BL/6 background relatively resistant to acute
TNBS-induced colonic injury (13), IRF-1/ mice demon-
strated severe colonic inflammation with significantly wors-
ened histological scores (Fig. 4A). The severity of colonic in-
flammation correlated with increased colonic Il23amRNA
and IL-23 protein expression (Fig. 4, B and C).
Colonic CD11b LPMCs from IL-10/ mice, predomi-
nantly composed of macrophages (4), were identified as the
major source of Il23a, Il12a, and Il12b (Fig. 5A). CD11b
LPMCs from IRF-1/IL-10/ mice demonstrated increased ba-
sal and heat-killed E. coli-activated Il23a expression com-
pared with IL-10/ and WT CD11b LPMCs (Fig. 5B). To
study the consequences of IRF-1 deficiency in the develop-
ment of spontaneous colitis, colonic inflammation and IL-23
expression were determined in IL-10/ and IRF-1/IL-10/
mice. 8-week-old IL-10/ mice demonstrated minimal or no
FIGURE 2. IRF-1 is a negative regulator of Il23a in macrophages. BMMs
from WT and IRF-1/ mice were cultured in the presence of LPS (100 ng/
ml; black bars) and IFN- (10 ng/ml; gray bars). Il23a mRNA (normalized to
-actin) (A) and IL-23 protein (B) were analyzed by real-time PCR and ELISA,
respectively. IL-12 p70 (C) and IL-12 p40 (D) protein expression was ana-
lyzed by ELISA. Data represent the mean  S.E. of three independent exper-
iments. *, p  0.05 versus WT LPS. E, WT BMMs were transfected for 18 h
with 100 nM scrambled siRNA or 100 nM IRF-1 siRNA and stimulated with
LPS (100 ng/ml) and IFN- (10 ng/ml). IRF-1 silencing was analyzed by West-
ern blotting. F, Il23a mRNA was determined by real-time PCR (normalized to
-actin). Data represent the mean  S.E. of three independent experiments.
*, p  0.05 versus WT LPS-activated BMMs.
FIGURE 3. IRF-1 deficiency alters NF-B subunit recruitment to the Il23a
promoter. RelA (A) and NF-B p50 (B) occupancy on the distal Il23a pro-
moter NF-B site was assessed in WT (solid lines) and IRF-1/ (dashed lines)
BMMs 30 and 60 min post-LPS (100 ng/ml) stimulation by ChIP. Results are
presented as enrichment (% input) of RelA or p50 DNA binding. Error bars
represent the mean  S.E. of three independent chromatin preparations. *,
p  0.05 versus 60 min post-LPS-stimulated WT BMMs. C, BMMs from WT
and p50/ mice were cultured in the presence of LPS (100 ng/ml; black
bars). D, Il23a mRNA (normalized to -actin) and IL-23 protein were ana-
lyzed by real-time PCR and ELISA, respectively. Data represent the mean 
S.E. of three independent experiments. *, p  0.05 versus WT LPS-activated
BMMs. u.d., undetected.
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inflammatory changes. However, age-matched littermate IL-
10/IRF-1/ mice developed significant colonic inflammation
(Fig. 5C). The severity of colonic inflammation correlated
with increased colonic Il23amRNA and IL-23 protein expres-
sion (Fig. 5, D and E). There were no significant differences in
colonic Il12a and Il12b expression between IL-10/ and
IRF-1/IL-10/ mice (supplemental Fig. 2, A and B). These
experiments implicate IRF-1 as a negative regulator of IL-23
in colonic inflammation, and suggest that a primary defect in
Il23a inhibition in colonic macrophages may underlie the
phenotype of severe colitis in an inducible and a spontaneous
experimental model.
DISCUSSION
We previously identified an anti-inflammatory role for
IFN- signaling in macrophages and experimental colitis
through attenuation of Il23a expression (4). In this study, an
IFN- signaling pathway that plays a role in IL-23 regulation
was further elucidated. An ISRE was identified within the
Il23a promoter involved in LPS induction and IFN- inhibi-
tion of Il23a, respectively. Notably, IRF-1 is a negative regula-
tor of Il23a expression. In mucosal immunity, IFN- and
IRF-1 may maintain homeostasis through inhibition of IL-23.
This hypothesis is supported in vivo through several experi-
mental observations. In colitis-prone mice, colonic CD11b
LPMCs are a primary source of IL-23 and a target for IFN-
during the initiation of colonic inflammation. Moreover,
TNBS-treated IRF-1/ mice and IRF-1/IL-10/ mice dem-
onstrated increased colonic inflammation and mucosal IL-23
expression compared with IL-10/ mice.
The IRF family is a group of transcription factors that re-
spond to signals from type I and II interferons. They share
significant homology in their N-terminal domains that inter-
act with a consensus DNA sequence, the ISRE (6). Several
IRFs participate in the expression of IL-12 family members.
IRF-1 is required for activation of the Il12a gene but does not
affect Il12b gene expression (11). IRF-8 activates both I112a
and Il12b gene expression (14). We identified an ISRE in the
Il23a promoter as a site for IRF-1 recruitment. In the absence
of IRF-1, LPS-induced Il23amRNA and IL-23 protein expres-
sion in BMMs was significantly enhanced. Although IRF-1
deficiency did not completely abrogate IFN--mediated inhi-
bition of IL-23, LPS- and IFN--induced IL-23 expression was
significantly greater in IRF-1/ BMMs than in LPS-activated
WT BMMs (in the absence of IFN-). It is plausible that in
FIGURE 4. IRF-1/ mice are more susceptible to TNBS-induced colitis.
8 –10-week-old WT and IRF-1/ mice were administered 2.5% (w/v) TNBS
in 40% ethanol intrarectally, and the intestines were harvested after 5 con-
secutive days of daily TNBS instillation. A, colitis scores of WT and IRF-1/
mice are presented as the sum total of four averaged scores from five re-
gions of the large intestine, graded by a pathologist blinded to genotype.
Colonic Il23a mRNA was examined using real-time PCR (B) and IL-23 protein
in cell-free colonic supernatants was examined by ELISA (C). Results are ex-
pressed as the mean  S.D. from eight mice per group. *, p  0.05 versus
WT TNBS-treated mice.
FIGURE 5. Increased mucosal expression of IL-23 in IRF-1/IL-10/ mice.
A, CD11b LPMCs were isolated from WT and IL-10/ mouse colons. Basal
expression of Il12a (white bars), Il12b (gray bars), and Il23a (black bars)
mRNAs was detected by real-time PCR. Results are expressed as -fold induc-
tion normalized to -actin, represent LPMCs pooled from three individual
mouse colons, and were replicated three times. B, CD11b LPMCs were iso-
lated from WT, IL-10/, and IL-10/IRF-1/ colons and activated with heat-
killed E. coli (multiplicity of infection of 10:1) for 2 h. Il23a and -actin mRNA
expression was detected by real-time PCR. Results are expressed as -fold
induction normalized to -actin, represent LPMCs pooled from three indi-
vidual mouse colons, and were replicated three times. C, colitis scores of
WT, IRF-1/, IL-10/, and IRF-1/IL-10/ mice were determined at 8
weeks of age. Results are presented as the sum total of four averaged scores
from five regions of the large intestine, graded by a pathologist blinded to
genotype. Colonic Il23a mRNA was examined using real-time PCR (D), and
IL-23 protein in cell-free colonic supernatants was examined by ELISA (E).
Results are expressed as the mean  S.E. from six mice per group. *, p 
0.05 versus IL-10/ mice.
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the absence of IRF-1, other IRFs play a compensatory inhibi-
tory role, consistent with the finding that in luciferase re-
porter assays, mutation of the ISRE abrogates the inhibitory
effect of IFN- (15). Alternatively, a combination of IRF-de-
pendent and IRF-independent mechanisms may exist through
which IFN- regulates Il23a expression (4). It should also be
noted that transient transfection of relatively small regulatory
regions in episomal reporter plasmids, although historically
useful to locate cis-acting elements, may not recapitulate the
complex regulation of the endogenous locus (16). Therefore,
complete reconciliation of the differences between endoge-
nous gene expression and the Il23a promoter-reporters de-
scribed herein will require the development of in vivo trans-
genic reporters using bacterial artificial chromosome
transgenes and/or knock-in strategies to track regulation of
the entire Il23a locus (16). With these limitations, our work
provides insight into paradoxical regulatory roles played by
cytokines and transcription factors that have long been con-
sidered to drive pro-inflammatory responses. Whereas IFN-
and IRF-1 are indispensible for optimal IL-12 expression by
macrophages and dendritic cells (6), both act as negative reg-
ulators of IL-23.
Il23a expression is dramatically reduced in macrophages
deficient in the NF-B family members c-Rel and RelA (5).
We recently demonstrated that IFN- inhibits LPS-induced
Il23a expression through attenuation of RelA and enhance-
ment of NF-B p50 recruitment to the Il23a promoter (4). In
contrast to c-Rel and RelA, NF-B family members p50 and
p52 have been shown to be important for transcriptional gene
repression (12, 17). Il23a gene expression is enhanced in p52-
deficient macrophages (17). IRFs also interact and cooperate
with other transcription factors to regulate target genes. IRF-
interacting transcription factors include NF-B, NFAT, and
STAT family members (10). Indeed, the ISRE in the Il23a
promoter is situated between two NF-B sites essential for
TLR-mediated Il23a induction (5). In the absence of IRF-1,
RelA recruitment to the Il23a promoter in macrophages is
prolonged, whereas p50 binding is abrogated, suggesting that
IRF-1 functionally interacts with NF-B. As a functional cor-
relate, we demonstrated that LPS-induced Il23a and IL-23
expression is in fact increased in NF-B p50/ BMMs.
The Il23a gene is activated through MyD88-dependent and
MyD88-independent pathways (18). LPS-induced MAPK
(ERK, JNK, and p38) activation has also been shown to regu-
late Il23a in macrophages (15, 18, 19). In the RAW 264.7
macrophage cell line, putative SMAD-2-, ATF-2-, IRF-3-, and
IRF-7-binding sites were identified through sequence homol-
ogies in the Il23a promoter. Deletions in the IRF-3, SMAD-3,
ATF-2, or NF-B sites, but not the IRF-7 sites, resulted in
significant loss of Il23a promoter activity in RAW 264.7 cells
activated with TLR3 or TLR7 agonists (15). Our newly identi-
fied ISRE is distinct from these previously described sites.
Moreover, mutations within our identified ISRE abrogate
LPS-mediated Il23a induction, suggesting that multiple IRF-
ISRE interactions may be essential for Il23a regulation.
Mice on a C57BL/6 background are relatively resistant to
colitis development (20). Interestingly, IRF-1/ mice devel-
oped more severe acute colonic injury following TNBS ad-
ministration compared with WT mice, correlating with in-
creased colonic IL-23 expression. Likewise, IRF-1 deficiency
also severely exacerbated IL-23-mediated colitis in IL-10/
mice on this resistant background. A limitation of this analy-
sis is that IRF-1 deficiency affects multiple innate and adapt-
ive immune pathways (21). For instance, IFN- directly inhib-
its TH17 differentiation (22), and IRF-1/ naïve T cells
produce more IL-17 in response to IL-23 (21). However, as in
vivo proof of concept that IRF-1directly mediates regulation
of Il23a, we demonstrated increased Il23a expression in the
colon and in colonic CD11b cells from IRF-1/IL-10/ mice
compared with IL-10/ mice. In vivo dissection of cell type-
specific effects of IRF-1 deficiency on innate and adaptive im-
munity will require the development of cell type-specific
IRF-1 deletions; nonetheless, these findings describe a novel
and paradoxical role for IRF-1 in inflammation, implicating
Il23a expression as an inciting event.
This study further elucidates signaling pathways that con-
tribute to the protective effects of IFN- in chronic inflamma-
tion (4). Similarly, in other models such as experimental auto-
immune encephalomyelitis and collagen-induced arthritis,
IFN- gene deletion or administration of anti-IFN- antibod-
ies leads to increased severity of disease (23, 24).
Differences in regulation of the p19 subunit of IL-23 and
the common p40 subunit of IL-12 and IL-23 may represent an
important in vivo checkpoint to shape the subsequent T cell
response. TH1 and TH17 responses are counter-regulatory (3).
IFN- and IRF-1 may act directly upon the macrophage to
attenuate TH17 responses through inhibition of IL-23. The
IL23R gene contains single nucleotide polymorphisms that
confer susceptibility to inflammatory bowel diseases (2). A
recent genome-wide association study in ulcerative colitis
patients revealed that the most significant chromosome
12q15 association signal was located in a region proximal to
IFNG (25). Moreover, a 250-kb risk haplotype within the
IBD5 locus on chromosome 5q31 associated with Crohn dis-
ease contains IRF1 (26). Therefore, converging genetic and
functional evidence suggests that IL-23, IFN-, and IRF-1 de-
fine an important pathway in experimental and human in-
flammatory bowel diseases.
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Regueiro, M. D., Steinhart, A. H., Targan, S. R., Schumm, L. P., Kistner,
E. O., Lee, A. T., Gregersen, P. K., Rotter, J. I., Brant, S. R., Taylor, K. D.,
Roeder, K., and Duerr, R. H. (2009) Nat. Genet. 41, 216–220
26. Reinhard, C., and Rioux, J. D. (2006) Inflamm. Bowel Dis. 12, 227–238
Characterization of an ISRE in the Il23a Promoter
1180 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 286 • NUMBER 2 • JANUARY 14, 2011
